475 related articles for article (PubMed ID: 35563515)
21. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.
Albini A; Di Guardo G; Noonan DM; Lombardo M
Intern Emerg Med; 2020 Aug; 15(5):759-766. PubMed ID: 32430651
[TBL] [Abstract][Full Text] [Related]
22. Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know?
Vitiello A; Ferrara F
Eur J Pharmacol; 2020 Sep; 883():173373. PubMed ID: 32679185
[TBL] [Abstract][Full Text] [Related]
23. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19.
Kai H; Kai M
Hypertens Res; 2020 Jul; 43(7):648-654. PubMed ID: 32341442
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
Simko F; Baka T
Clin Sci (Lond); 2021 Apr; 135(8):1009-1014. PubMed ID: 33881142
[TBL] [Abstract][Full Text] [Related]
25. [Effect of components of the renin-angiotensin system, rs2106809 polymorphism of the
Zuraeva ZT; Vikulova OK; Malysheva NM; Nikankina LV; Zaytceva NV; Sukhareva OY; Shamhalova MS; Shestakova MV; Mokrysheva NG
Probl Endokrinol (Mosk); 2023 Aug; 69(4):21-31. PubMed ID: 37694864
[TBL] [Abstract][Full Text] [Related]
26. Potential Implications of Angiotensin-converting Enzyme 2 Blockades on Neuroinflammation in SARS-CoV-2 Infection.
Paul D; Mohankumar SK; Thomas RS; Kheng CB; Basavan D
Curr Drug Targets; 2022; 23(4):364-372. PubMed ID: 34732115
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019.
Suh SH; Ma SK; Kim SW; Bae EH
Korean J Intern Med; 2021 Mar; 36(2):247-262. PubMed ID: 33617712
[TBL] [Abstract][Full Text] [Related]
28. Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.
Sackin H
Med Hypotheses; 2021 Jul; 152():110609. PubMed ID: 34048987
[TBL] [Abstract][Full Text] [Related]
29. Focus on clinical practice: angiotensin-converting enzyme 2 and corona virus disease 2019: pathophysiology and clinical implications.
Barillà F; Bassareo PP; Calcaterra G; Romeo F; Mehta JL
J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):630-633. PubMed ID: 32740495
[TBL] [Abstract][Full Text] [Related]
30. New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System.
Sansoè G; Aragno M
J Renin Angiotensin Aldosterone Syst; 2023; 2023():3362391. PubMed ID: 37476705
[TBL] [Abstract][Full Text] [Related]
31. Renin-angiotensin system modulators in COVID-19 patients with hypertension: friend or foe?
Shylesh C M S; V S A; S K K; P UD
Clin Exp Hypertens; 2022 Jan; 44(1):1-10. PubMed ID: 34414841
[No Abstract] [Full Text] [Related]
32. Angiotensin converting enzyme 2 at the interface between renin-angiotensin system inhibition and coronavirus disease 2019.
Siri-Angkul N; Chattipakorn SC; Chattipakorn N
J Physiol; 2020 Oct; 598(19):4181-4195. PubMed ID: 32710575
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells.
Pires de Souza GA; Osman IO; Le Bideau M; Baudoin JP; Jaafar R; Devaux C; La Scola B
Front Cell Infect Microbiol; 2021; 11():639177. PubMed ID: 34178717
[TBL] [Abstract][Full Text] [Related]
34. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
[TBL] [Abstract][Full Text] [Related]
35. Repurposing of RAS-Pathway Mediated Drugs for Intestinal Inflammation Related Diseases for Treating SARS-CoV-2 Infection.
Sinha A; Vaggu RG; Swain R; Patnaik S
Curr Microbiol; 2023 Apr; 80(6):194. PubMed ID: 37106165
[TBL] [Abstract][Full Text] [Related]
36. Discovery and characterization of ACE2 - a 20-year journey of surprises from vasopeptidase to COVID-19.
Hooper NM; Lambert DW; Turner AJ
Clin Sci (Lond); 2020 Sep; 134(18):2489-2501. PubMed ID: 32990314
[TBL] [Abstract][Full Text] [Related]
37. Lung and Kidney ACE2 and TMPRSS2 in Renin-Angiotensin System Blocker-Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19.
Batchu SN; Kaur H; Yerra VG; Advani SL; Kabir MG; Liu Y; Klein T; Advani A
Diabetes; 2021 Mar; 70(3):759-771. PubMed ID: 33310740
[TBL] [Abstract][Full Text] [Related]
38. The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure.
Angeli F; Zappa M; Reboldi G; Gentile G; Trapasso M; Spanevello A; Verdecchia P
Eur J Intern Med; 2023 Mar; 109():12-21. PubMed ID: 36528504
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.
Vieira C; Nery L; Martins L; Jabour L; Dias R; Simões E Silva AC
Curr Drug Targets; 2021; 22(3):254-281. PubMed ID: 33081670
[TBL] [Abstract][Full Text] [Related]
40. Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection.
Gao X; Zhang S; Gou J; Wen Y; Fan L; Zhou J; Zhou G; Xu G; Zhang Z
J Infect; 2022 Oct; 85(4):418-427. PubMed ID: 35793758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
